Jpmorgan Chase & CO Atri Cure, Inc. Transaction History

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Atri Cure, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 254,466 shares of ATRC stock, worth $8.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

254,466

Previous 365,183 30.32%

Holding current value

$8.8 Million

Previous $11.2 Million 26.44%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$30.4 - $42.4 $3.37 Million - $4.69 Million	-110,717 Reduced 30.32%	254,466 $8.21 Million
Q4 2024 Feb 12, 2025	BUY	$27.02 - $38.2 $2.97 Million - $4.2 Million	110,039 Added 43.13%	365,183 $11.2 Million
Q3 2024 Dec 26, 2024	SELL	$20.34 - $29.5 $1.42 Million - $2.07 Million	-70,003 Reduced 21.53%	255,144 $7.15 Million
Q3 2024 Nov 08, 2024	SELL	$20.34 - $29.5 $1.42 Million - $2.07 Million	-70,003 Reduced 21.53%	255,144 $7.15 Million
Q2 2024 Dec 26, 2024	BUY	$19.86 - $29.09 $1.39 Million - $2.04 Million	70,003 Added 27.44%	325,147 $7.4 Million
Q2 2024 Aug 12, 2024	SELL	$19.86 - $29.09 $2.9 Million - $4.24 Million	-145,865 Reduced 30.97%	325,147 $7.4 Million
Q1 2024 Dec 26, 2024	BUY	$28.21 - $37.78 $6.09 Million - $8.16 Million	215,868 Added 84.61%	471,012 $14.3 Million
Q1 2024 May 10, 2024	BUY	$28.21 - $37.78 $3.24 Million - $4.34 Million	114,779 Added 32.22%	471,012 $14.3 Million
Q4 2023 Dec 26, 2024	BUY	$32.99 - $43.25 $3.33 Million - $4.37 Million	101,089 Added 39.62%	356,233 $12.7 Million
Q4 2023 Feb 12, 2024	BUY	$32.99 - $43.25 $1.13 Million - $1.48 Million	34,223 Added 10.63%	356,233 $12.7 Million
Q3 2023 Nov 14, 2023	SELL	$41.12 - $57.73 $862,574 - $1.21 Million	-20,977 Reduced 6.12%	322,010 $14.1 Million
Q2 2023 Aug 11, 2023	BUY	$40.44 - $49.6 $10.9 Million - $13.4 Million	269,454 Added 366.44%	342,987 $16.9 Million
Q1 2023 May 18, 2023	BUY	$35.87 - $47.22 $2.07 Million - $2.72 Million	57,701 Added 364.46%	73,533 $3.05 Million
Q1 2023 May 11, 2023	SELL	$35.87 - $47.22 $1.62 Million - $2.13 Million	-45,049 Reduced 74.0%	15,832 $656,000
Q4 2022 Feb 13, 2023	BUY	$33.48 - $47.45 $208,948 - $296,135	6,241 Added 11.42%	60,881 $2.7 Million
Q3 2022 Nov 14, 2022	BUY	$38.25 - $52.62 $121,596 - $167,278	3,179 Added 6.18%	54,640 $2.14 Million
Q2 2022 Aug 11, 2022	BUY	$35.1 - $66.01 $368,339 - $692,708	10,494 Added 25.62%	51,461 $2.1 Million
Q1 2022 May 11, 2022	SELL	$57.43 - $71.39 $1.28 Million - $1.59 Million	-22,323 Reduced 35.27%	40,967 $2.69 Million
Q4 2021 Feb 10, 2022	BUY	$63.4 - $87.14 $1.94 Million - $2.66 Million	30,576 Added 93.46%	63,290 $4.4 Million
Q3 2021 Nov 12, 2021	BUY	$69.28 - $84.46 $2.27 Million - $2.76 Million	32,714 New	32,714 $2.28 Million

Others Institutions Holding ATRC

# of Institutions

238

Shares Held

52M

Call Options Held

32.6K

Put Options Held

4.5K

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.6B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Atri Cure, Inc. Transaction History